Dan Sharp, Director, OTC, UT Austin
Download
Report
Transcript Dan Sharp, Director, OTC, UT Austin
The University of Texas at Austin
Office of Technology Commercialization
Creating New Approaches to Innovation
P R E S E N T E D B Y D A N S H A R P, D I R E C T O R
TO SB IR / ST T R SUMMIT & CON F ER EN C E
J A N UA RY 19 , 20 1 2
The University of Texas at Austin
51,000+ students; 3,344 faculty
$642MM in annual research funding
$25.6MM/year revenue from licensing and royalty
Over 1,000 patents filed in last 5 years
UT System ranked No. 3 by Patent Scorecard™
$60MM industry-sponsored research from leading companies;
e.g., Abbott, Chevron, Merck, ExxonMobil, Intel, Cisco,
Samsung, BASF, Boeing, Lockheed Martin, Pfizer
Office of Technology Commercialization:
Who we are
The Office of Technology Commercialization is responsible for
the efficient transfer of university discoveries to the marketplace
for the benefit of society. To support the university's research
mission, OTC:
Evaluates, protects, markets, and licenses the university’s
inventions and software
Promotes collaboration with industry, investors, and others
within the tech commercialization ecosystem
Informs the university's faculty on patent protection and
commercialization processes
OTC reports to the Office of the Vice President for Research
Office of Technology Commercialization:
What we do
Initial technology disclosure evaluation and due diligence
Patent strategy development
Patent application and prosecution
Business development
Interaction and negotiation with potential licensees
Marketing and faculty outreach
Tech transfer: Licensing technology to third parties
Leveraging UT technologies into funded, emerging growth
companies
License and patent enforcement
Office of Technology Commercialization:
Services we provide to you
Legal introductions (corporate formation and funding
transactions)
Funding introductions (angels, VCs, corporate/strategic
partners)
Management introductions
Seasoned entrepreneurs with solid track records and domain
expertise to develop business model and strategy
Traditional “business development”
Leverage the collective OTC network and that of UT Austin to
accelerate market validation, feedback, and company/technology
development
Proper handoff to the appropriate service providers/business
partner
Office of Technology Commercialization:
Cash Flow
Where we play
Company
Formation
Time
Office of
Austin
Technology
Technology
Commercialization Incubator Angels
Venture Capital
Office of Technology Commercialization:
How we educate faculty
Colloquium on Commercialization Series
October 14, 2011 – “Startup to IPO: Building for Success”
November 9, 2011 – “Licensing and Corporate Partnering”
December 6, 2011 – “Inventor of the Year Ceremony and
Reception”
February 22, 2012 – “What You Need to Know About Patents
For faculty, postdocs/grad students, and invited guests only
To learn more, visit: www.otc.utexas.edu/Events/Colloquium/
Send inquiries to [email protected]
Increase Quality, Not Quantity, of
Disclosures and New Patent Filings
An iterative process with professors and students that can lead
to stronger, more prominent, and more valuable patent
portfolios
Getting to “No” faster, in order to spend more quality time with
potential winners
Engaging high-quality patent attorneys earlier in the process to
discuss, evaluate, and recommend optimum patent strategies
Results
Disclosures/patent filings
Legal fees and administrative costs
Revenue from higher-quality tech transfer
New US Patents Filed, FY 2010-11
COCKRELL SCHOOL OF ENGINEERING . . . . . . . . . . . . . . . . . . . .
Biomedical Engineering
11
Chemical Engineering
19
Civil, Architectural and Environmental Engineering
4
Electrical and Computer Engineering
11
Mechanical Engineering
12
Petroleum and Geosystems Engineering
8
COLLEGE OF NATURAL SCIENCES . . . . . . . . . . . . . . . . . . . . . . . .
Chemistry and Biochemistry
14
Computer Science
2
Institute for Cellular and Molecular Biology
1
Physics
1
School of Biological Sciences
10
VICE PRESIDENT FOR RESEARCH . . . . . . . . . . . . . . . . . . . . . . . .
Applied Research Laboratories (ARL)
2
Center for Electromechanics
3
Institute for Advanced Technology
1
SCHOOL OF PHARMACY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pharmaceutics
4
Pharmacy Practice
2
COLLEGE OF LIBERAL ARTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Psychology
3
0
2
4
6
8
10
12
14
16
18
20
N.B.: Total equals more than 100% of patent count because of multiple inventors in different departments.
Impact of Focus on Quality
Higher quality patent filings
200
180
160
182
155
133
140
120
FY09-10
100
80
69
60
40
20
0
Disclosures
New patent filings
FY10-11
FY 10/11 – Licensing Revenue: $25,641,730
$12,140,451
$68,693
$2,114,440
Inventors (44.1%)
Departments (8.2%)
Third Parties (0.3%)
$11,318,147
©2011, Office of Technology Commercialization
Retained by UT Austin (47.3%)
11
The Austin and Texas Technology Ecosystem
Research
and
Innovation
Technology
Development
Government and
Industry Engagement and Funding
Licensing and
New Company
Formation
Faculty and
Students
Venture
Capital
Success
Stories